• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FDA approval

Roche
Pharma

Roche’s Gazyva wins first FDA nod for membranous nephropathy

Besides lupus nephritis, idiopathic nephrotic syndrome and membranous nephropathy, Gazyva also awaits an FDA decision in systemic lupus erythematosus.
Angus Liu Nov 16, 2026 11:00am
Green light double green light approval approvals FDA FDA nod

AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods

Nov 16, 2026 10:39am
AZ

AZ's Imfinzi keeps MIBC race against Keytruda hot with FDA nod

Nov 13, 2026 5:40pm
Takeda

Orzeyful gets off to races in US with 'lighter' DEA schedule

Nov 12, 2026 11:16am
Stamp with blue ink that says FDA Approved

Merck KGaA's Pimjetmi wins FDA approval in rare tumor disorder

Nov 10, 2026 5:45pm
Bayer cross

Bayer nabs 1st-in-class FDA nod for stroke med asundexian

Nov 9, 2026 9:10pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings